"Yttrium Radioisotopes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Unstable isotopes of yttrium that decay or disintegrate emitting radiation. Y atoms with atomic weights 82-88 and 90-96 are radioactive yttrium isotopes.
| Descriptor ID |
D015021
|
| MeSH Number(s) |
D01.268.558.975.500.800 D01.268.956.890.500.800 D01.496.749.960 D01.496.943.800 D01.552.550.975.500.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Yttrium Radioisotopes".
Below are MeSH descriptors whose meaning is more specific than "Yttrium Radioisotopes".
This graph shows the total number of publications written about "Yttrium Radioisotopes" by people in this website by year, and whether "Yttrium Radioisotopes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Yttrium Radioisotopes" by people in Profiles.
-
LI-RADS radiation-based treatment response algorithm for HCC: what to know and how to use it. Abdom Radiol (NY). 2025 May; 50(5):2012-2021.
-
Modified Radiation Lobectomy Strategy of Radioembolization for Right-Sided Unresectable Primary Liver Tumors. J Vasc Interv Radiol. 2024 Jul; 35(7):989-997.e2.
-
Tumor Size and Watershed Area Correlate with Incomplete Treatment and Tumor Progression after Selective Radioembolization for Hepatocellular Carcinoma. J Vasc Interv Radiol. 2024 May; 35(5):712-721.e3.
-
Transarterial Radioembolization for Management of Hepatocellular Carcinoma. Oncologist. 2024 Feb 02; 29(2):117-122.
-
Quantitative differences in volumetric calculations for radiation dosimetry in segmental Y90 treatment planning using hybrid angiography-CT compared with anatomic segmentation. Br J Radiol. 2024 Feb 02; 97(1154):353-362.
-
Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma. Eur Radiol. 2024 Apr; 34(4):2374-2383.
-
Contemporary applications of Y90 for the treatment of hepatocellular carcinoma. Hepatol Commun. 2023 10 01; 7(10).
-
Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience. J Vasc Interv Radiol. 2023 11; 34(11):1970-1976.e1.
-
Yttrium-90 Radioembolization and Concomitant Systemic Gemcitabine, Cisplatin, and Capecitabine as the First-Line Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma. J Vasc Interv Radiol. 2023 04; 34(4):702-709.
-
Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort. Cardiovasc Intervent Radiol. 2022 Aug; 45(8):1117-1128.